Why the study?
Does oral and transdermal nicotine influence blood pressure, haematology, and coagulation indices in smokers?
Does oral and transdermal nicotine influence blood pressure, haematology, and coagulation indices in smokers?
Oral and transdermal nicotine replacement therapy does not adversely influence blood pressure or measured haematology and coagulation indices compared to smoking cessation.
Answers are grounded in this paper and cite their sources.
Observational data support NRT safety on BP and coagulation indices; leaves open need for randomized confirmation.
Nicotine is helpful in stopping smoking but its influence on cardiovascular risk factors is incomplete. Our aim was to determine its effect on blood pressure, routine haematology indices, and coagulation indices relevant to thrombosis. Eighteen subjects were seen whilst smoking (cotinine levels 1119 +/- 414 ng/ml), again after stopping smoking but while using nicotine chewing gum and/or skin patches (392 +/- 198 ng/ml), and again when not using nicotine (cotinine undetectable). There were no significant changes in blood pressures, platelet count, mean platelet volume, viscosity or anti-thrombin III. However, white blood cell count (p = 0.003), lymphocyte count (p = 0.016), red blood cell count (p = 0.02), haemoglobin (p <0.001), fibrinogen (p <0.001) and von Willebrand factor (p = 0.001) all fell between the first and second samples (when still using nicotine) but not between the second and third samples (when off nicotine). Oral and/or transdermal nicotine does not influence blood pressure or the haematology and coagulation indices we have measured.
No takes yet. Share an insight, caveat, or question.
Blann et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: